Thalidomide and Epoetin Alfa in Treating Anemia in Patients With Myelodysplastic Syndrome

Clinical trial NCT00053001 · COMPLETED

Trial details

NCT number: NCT00053001
Sponsor: Fallon Clinic
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Anemia Leukemia Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms

Start date: 2001-06-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.